• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SD BIOSENSOR, INC. PILOT COVID-19 AT-HOME TEST; CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SD BIOSENSOR, INC. PILOT COVID-19 AT-HOME TEST; CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM Back to Search Results
Catalog Number 99COV200L-EN02
Device Problems False Negative Result (1225); Nonstandard Device (1420); Contamination /Decontamination Problem (2895)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/29/2023
Event Type  malfunction  
Event Description
On four consecutive days i used sd biosensor pilot covid-19 at-home tests with lot #53k38p2t1 that were later recalled by the fda due to bacterial contamination.I did not have any signs of bacterial infection, but i suspect false negative results, which is listed as a concern in the recall information.I used the tests because i had covid symptoms starting 3 to 4 days after a confirmed exposure.I continued to have symptoms for 3 to 4 weeks.After a week of illness i called my health care provider (b)(6), and a nurse there advised that i did not need to come in for a pcr test, partly because of the negative home test results which are now in question.Reference reports mw5117581, mw5117582, mw5117584.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PILOT COVID-19 AT-HOME TEST
Type of Device
CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM
Manufacturer (Section D)
SD BIOSENSOR, INC.
MDR Report Key16946747
MDR Text Key315417155
Report NumberMW5117583
Device Sequence Number1
Product Code QKP
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 05/11/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/16/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date05/16/2023
Device Catalogue Number99COV200L-EN02
Device Lot Number53K38P2T1
Was Device Available for Evaluation? Yes
Patient Sequence Number1
Treatment
ATORVASTATIN 10MG 1X DAY ; CBD OIL, 20MG 1X MORNING, 2X BEDTIME ; CETIRIZINE 10MG 1 OR 2X DAY ; FLAXSEED OIL 1200MG 2X DAY ; GABAPENTIN 600MG 2X DAY ; GARLIC 2000MG 2X DAY ; LORAZEPAM 0.5MG, USED RARELY FOR SLEEP ISSUES; VITAMIN D3 1000IU 1X DAY DURING THE DARKER MONTHS OF THE YEAR
Patient Age62 YR
Patient SexMale
Patient Weight91 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-